Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-060730

Options or other derivatives

  • Director acquired 32,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schor Chen · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-25 Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) +32,800 $14.75 2030-11-24 32,800 32,800 D
Loading xslF345X03/doc4.xml…